The report titled ‘Global Yellow Fever Market - Growth, Share, Opportunities, and Competitive Analysis, 2023 - 2032’ offers strategic visions into the global yellow fever market along with the market size (Revenue - US$ Mn).
The said research study covers in-depth analysis of multiple market segments based on type, application, end-user and study across different topographies. The report is also inclusive of competitive profiling of the leading yellow fever vendors, and latest developments. Yellow fever is an epidemic that spreads through the bite of an infected mosquito that transmits yellow fever virus to the human.
The disease is primarily prevalent in sub-Saharan Africa and South America however, in the past there have been various cases of yellow fever in Europe and North America. The infection from yellow fever can result in hemorrhagic fever with high mortality rate. There is inadequacy for yellow fever treatment hence prevention through immunization is the most important method of controlling yellow fever outbreaks. Effective vaccination for this disease has been available for over 80 years and this has helped in significant reduction of occurrence of this disease globally.
The global yellow fever market was valued at US$ 61.2 Mn in 2017 and is expected to expand at a CAGR of 3.9% from 2018 to 2024.
The key factor driving growth of global yellow fever market is the rising demand for yellow fever vaccination from the South American and Sub-Sahara African region. There have been severe outbreaks in African countries such as Nigeria, Ghana, Angola, Guinea, Congo and Uganda among others and in South American countries including Brazil, Paraguay, Colombia, Bolivia and others.
Furthermore, growing number of international travelers, unhygienic lifestyle, rising awareness related to the availability of yellow fever treatment, and constant efforts by key organizations such as the UNICEF and WHO are also driving the growth of the global yellow fever market. On the contrary, mild side effects for yellow fever are hampering the growth of yellow fever market in the current scenario.
The global yellow fever market has been segmented based on type, application, end-user, and geography. Based on types, the global yellow fever market has been segmented into monovalent vaccines, and multivalent vaccines. Based on applications, the global yellow fever market has been segmented into routine immunization, preventive campaigns, and outbreak response. The various end-users of the yellow fever vaccines are pediatrics and adults. Among the various end-users, pediatrics accounted for larger share of the market owing to increasing vaccination activities in infants to protect against yellow fever. This segment is further expected to remain dominant in the near future expanding at a CAGR of 4.3% from 2018 to 2024. The market for yellow fever vaccine in adults is also expected to showcase high growth thereby boosting the demand for yellow fever over the forecast period from 2022 to 2032. Based on geography, the global yellow fever market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
North America comprises U.S., Canada, and Mexico whereas Europe would primarily cover Germany, France, UK, Italy, and Rest of Europe. The key countries included under Asia Pacific are China, Japan, India, Australia, and Rest of Asia Pacific. In Latin America, Brazil, Argentina, and Rest of Latin America are the key segments whereas in Middle East & Africa, South Africa and Rest of MEA are the key segments covered in the report.
Middle East & Africa accounted for the largest share in the global yellow fever market; it is further projected to dominate the global market by 2024. Latin America accounted for second largest market share whereas North America and Europe are projected to grow at slow pace owing to lower outbreak led by significant prevention activities. The global yellow fever market is concentrated with top manufacturers having strong hold on the global market.
Some of the key manufacturers of yellow fever vaccine in the global market include Pfizer, Inc., Glaxosmithkline, Plc, Merck & Co., Inc., Sanofi Pasteur, CSL Limited, Emergent Biosolutions, Inc., Johnson & Johnson, Medimmune, LLC, Astellas Pharma Inc., Serum Institute of India, and Bio-Manguinhos among others.
Market Segmentation:
By Type
- monovalent vaccines
- multivalent vaccines
By Application
- routine immunization
- preventive campaigns
- outbreak response.
By End-user
By Geography
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- South America
